医脉通科技有限公司（股票代码：02192）于2026年4月8日发布公告，披露已发行股本变动。根据公告，公司于2026年4月2日及4月8日，分别向行使购股权的员工及两位董事共计发行295,000股普通股，其中4月2日发行20,000股，约占发行前已发行股本的0.0027%；4月8日发行275,000股，约占发行前已发行股本的0.0372%。发行价格均为每股人民币0.38。
本次发行完成后，公司已发行股本由738,963,750股增加至739,258,750股。公司在公告中确认已根据董事会授权推进本次股份发行，并遵守香港联交所相关上市规则和适用法律。
本公告由公司秘书杨艳玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.